Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
Upcoming Events
Morgan Stanley 23rd Annual Global Healthcare Conference
Past Events
European Alliance of Associations for Rheumatology (EULAR) 2025 Congress
Barcelona, Spain